Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
DSGN
LXRX
Add up to 3 more stocks
DSGN
Design Therapeutics, Inc.
-0.72%
$12.33-0.09Delayed quote: Oct 6, 2026, 11:20 AM EDT
Market Cap
$770.09M
52W Range
$5.28 - $17.25
LXRX
Lexicon Pharmaceuticals, Inc.
+1.34%
$1.76+0.02Delayed quote: Oct 6, 2026, 11:20 AM EDT
Market Cap
$783.25M
52W Range
$0.51 - $2.68
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.82 | 4.49 |
| P/S Ratio | N/A | 18.89 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 98.8% |
| Operating Margin | 0.0% | -98.2% |
| Net Margin | 0.0% | -147.4% |
| ROE | -35.1% | -35.0% |
| ROA | -32.9% | -24.4% |
| ROIC | -38.9% | -23.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 18.86 | 13.37 |
| Quick Ratio | 18.86 | 13.29 |
| Debt/Equity | 0.01 | 0.34 |
| Interest Coverage | N/A | -5.87 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.